An observational approach is recommended in newly diagnosed children with immune thrombocytopenia (ITP) at low risk of bleeding; however, there is no standard definition of risk. A standardized clinical assessment and management plan (SCAMP R ), a modifiable practice guideline, was implemented and revised (SCAMP-1 and SCAMP-2) and applied to 71 newly diagnosed patients with ITP. The Buchanan and Adix bleeding score guided treatment and was modified by stratifying by low-and high-risk grade 3 bleeding in SCAMP-2. Observation rates increased from 40% to 74% from SCAMP-1 to SCAMP-2 (P < 0.05) with no bleeding complications. We propose a modified bleeding score that increased observation rates in low-risk patients with ITP.
INTRODUCTION
Immune thrombocytopenia (ITP) is usually an acute, self-resolving illness in children. While severe bleeding, specifically intracranial hemorrhage (ICH), is the most feared complication, its incidence is rare.
In observational cohorts, the reported incidence of severe bleeding in children is approximately 1/800. [1] [2] [3] It is not clear that pharmacologic therapy prevents ICH or other severe bleeding. 4, 5 Both the American Society of Hematology (ASH) and an International Working Group (IWG) recommend pharmacologic treatment based on bleeding and observation without drug therapy in newly diagnosed patients who do not have severe bleeding. 6, 7 There are several bleeding severity instruments for ITP but no consensus regarding their use.
The 2011 ASH ITP guidelines define "mild bleeding" as bruising or petechiae and recommend observation in patients with these symptoms. 6 The IWG also recommends observation in such patients and subsequently proposes the ITP Bleeding Assessment Tool to define severe bleeding requiring treatment. 7, 8 Other bleeding scales have been less clear about specific thresholds for treatment. 9 The Buchanan and Adix bleeding scale provides an overall grade from 0 to 5 which incorporates skin, oral, and mucosal bleeding. 11 Grade 0-2 includes bleeding of the skin only, grade 3 includes mucosal bleeding, and grade 4-5 is any bleeding that requires immediate medical attention or is life threatening (Table 1) . Because it is quick, easy to apply, and has high inter-rater reliability for non-cutaneous bleeding, patients with ITP seen at our institution are assigned an overall Buchanan and Adix score by their primary hematologist. 11 A standardized clinical assessment and management plan (SCAMP R ) is a modifiable practice guideline. An ITP-specific SCAMP was developed by local expert consensus for newly diagnosed children with ITP and implemented at our institution. 12 The SCAMP was designed to decrease practice variation, identify and learn from deviations in decision making, and decrease resource utilization by increasing observation rates in low-risk patients. This report describes the outcomes of utilizing an ITP SCAMP at a single pediatric institution and proposes a modified Buchanan and Adix score that may facilitate employing an observation approach in patients with low risk of serious bleeding.
METHODS
A SCAMP was developed by consensus of local ITP experts at Categorical data were summarized with percentages, while continuous data were summarized as median and range. Groups were compared using a Fisher's exact test or Wilcoxon rank sum test. A P value < 0.05 was considered significant. Analysis was performed using SAS v9.4 (SAS Institute, Cary, NC).
RESULTS
SCAMP-1 was applied to 40 patients and SCAMP-2 to 31 patients.
Median age, platelet count, and bleeding scores at presentation were not significantly different among the two groups ( Table 2 ). The initial observation rate in SCAMP-1 was 40% (16/40), while in SCAMP-2, the observation rate increased significantly to 74% (23/31, P < 0.05).
In patients with bleeding scores ≤ grade 2, the recommendation of observation without drug therapy was followed, 16/17 (94%) in Of the 39 patients initially observed in SCAMP-1 and SCAMP-2, 37 (95%) ultimately received no pharmacologic therapy and were observed at least until 6 months from initial diagnosis. One patient in SCAMP-1 was started on prednisone for low-risk grade 3 bleeding, and one in SCAMP-2 received 6-mercaptopurine after developing autoimmune hemolytic anemia. There were no high-risk grade 3 or grade 4 bleeding events in any of the initially observed patients.
DISCUSSION
An ITP SCAMP, based on local expert consensus, was successfully implemented within a hematology program at a large academic center. SCAMP-1 did not increase the observation rate of newly diagnosed pediatric patients with ITP, which has historically been approximately 40% at our institution. Following the ASH guidelines with regard to treatment based on bleeding manifestations, there is agreement that grade 0-2 bleeding warrants observation whereas pharmacologic treatment is indicated for grade 4-5 bleeding. However, appropriate management for grade 3 bleeding is controversial;
thus, SCAMP-2 implemented a modified grading system that discriminated between relatively higher and lower risk grade 3 bleeding. 13 This Parental anxiety (1) Observation for bleeding (1) Distance from the hospital (1) a Some patients exited the SCAMP earlier or were lost to follow-up.
more precise characterization of grade 3 bleeding led to a significant and safe increase in the rate of observation.
Since SCAMP-2 was associated with less grade 3 bleeding than SCAMP-1, the modified Buchanan and Adix score was retrospectively applied to the cohort on SCAMP-1. By doing so, the observation rate increased from 43% to 85% with 17 additional patients observed.
Given this finding, it is unlikely that the increased observation rate using the modified Buchanan and Adix score was solely related to less grade 3 bleeding in SCAMP-2.
This study has several limitations. Since the SCAMP was implemented at a single institution, each version was applied to only a small cohort of patients. Furthermore, the impact of the modified Buchanan
and Adix score was difficult to assess, because providers were not required to follow guidelines within the SCAMP concept.
The ITP SCAMP increased consistency and observation rates in the management of newly diagnosed ITP. A similar model could be applied at other institutions. We propose the clinical use of a modified Buchanan and Adix scoring instrument, which stratifies low-and high-risk bleeding to different treatment approaches and might help to increase observation rates and diminish overall disease burden.
